- Home>
- Watch Topics>
- Bone and Joint Disease
Bone and Joint Disease
The latest information on arthritis, bisphosphonates, osteoporosis, joint pain, and more, drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.
Thiazolidinediones and Risk for Fractures
- General Medicine
- Summary and Comment
- Subscription required
In an observational study, users of TZDs had higher risk for fractures than those taking other antidiabetes medications.
- By Jamaluddin Moloo, MD, MPH
- May 8, 2008
- Covering Arch Intern Med 2008 Apr 28
Alendronate and Risk for Atrial Fibrillation
- General Medicine
- Summary and Comment
- Subscription required
Because of inconsistent results across several studies, it's still unclear whether oral bisphosphonates increase risk for atrial fibrillation.
- By Jamaluddin Moloo, MD, MPH, and Paul S. Mueller, MD, MPH, FACP
- May 6, 2008
- Covering Arch Intern Med 2008 Apr 28
Be Still My Heart — Bisphosphonates Not Linked to Arrhythmias
- Women's Health
- Summary and Comment
- Subscription required
Use of oral bisphosphonates did not increase risk for atrial fibrillation and flutter.
- By Wendy S. Biggs, MD
- April 17, 2008
- Covering BMJ 2008 Apr 12
Should We Be Concerned About Jaw Osteonecrosis with Oral Bisphosphonates?
- General Medicine
- Feature
- Free
BRONJ probably occurs rarely with oral bisphosphonate therapy, but the true incidence isn’t clear yet.
- By Allan S. Brett, MD, and Peter B. Lockhart, DDS
- April 8, 2008
A New Approach to Osteoporosis and Fracture Risk
- General Medicine
- Summary and Comment
- Subscription required
A new statistical model predicts 10-year risk for hip and other major fractures.
- By Allan S. Brett, MD
- April 8, 2008
- Covering Osteoporos Int 2008 Apr
Oral Bisphosphonates Do Not Increase Risk for Atrial Fibrillation and Flutter
- General Medicine
- Summary and Comment
- Subscription required
A previous finding of increased risk for atrial fibrillation and flutter after IV bisphosphonate was not observed in orally treated patients.
- By Paul S. Mueller, MD, MPH, FACP
- April 8, 2008
- Covering BMJ 2008 Mar 11
Effect of Anastrozole on Bone-Mineral Density
- Oncology and Hematology
- Summary and Comment
- Subscription required
Five years of anastrozole therapy did not lead to osteoporosis for any woman with normal BMD at baseline.
- By Barbara A. Murphy, MD
- March 18, 2008
- Covering J Clin Oncol 2008 Mar 1
A Bad Break in Epilepsy?
- Psychiatry
- Summary and Comment
- Subscription required
Deficits in bone mineral density are found in children with epilepsy, and these deficits worsen as illness duration increases.
- By Jonathan Silver, MD
- March 10, 2008
- Covering Neurology 2008 Jan 15
Healthcare Expenditures for Spine Problems Have Increased
- Emergency Medicine
- Summary and Comment
- Subscription required
At the same time, patient functioning has decreased.
- By John A. Marx, MD, FAAEM, FACEP
- February 29, 2008
- Covering JAMA 2008 Feb 13
Oral Bisphosphonates and Oral Health
- Women's Health
- Summary and Comment
- Subscription required
Oral BP administration was not associated with increased risk for ONJ.
- By Wendy S. Biggs, MD
- February 28, 2008
- Covering J Am Dent Assoc 2008 Jan